Recent Transactions

  • Feb

    €22m equity commitment for the acquisition of a European company, in the field of destocking of consumer goods, with revenue of c. €40m and EBITDA of c. €5m, in a buy-and-build strategy.

  • Dec

    $17m equity commitment for the acquisition of a landscaping business in Florida, with revenue of c. $50m and EBITDA of $7.5m, sponsored by a NY-based GP with an exceptional track record.

  • Dec

    Restructuring of a $175m mid-market buyout fund vintage 2005, managed by a NY-based GP

  • Jun

    $48m equity financing, of the acquisition of a US-based provider of air cargo and logistics solutions with revenue of c. $260m and EBITDA of $32m

About Us

Our Strategy
A Tailor-MadeProblem-Solving Approach

Our strategy is to identify isolated or systemic problems within the private equity and venture capital asset class, and structure ad hoc transactions to address individual situations.Once we have a workable solution for a systemic problem, we package it as a product, and offer it to other market players facing the same issues.

We have built our success in structuring transactions using a problem-solving approach. We have distinguished ourselves through our market expertise, creativity and innovation. We have built a reputation for timeliness, discretion and integrity.

Our Organization
RainMakers is a modern organization highly relying on virtual collaboration and state of the art infrastructure. Most middle and back office functions are outsourced so that we can focus on what we are good at.


Senior Management

Jim Soleymanlou
Founder and Managing Partner

Jim founded RainMakers in 2004 and has been behind the development of the firm and the execution of each transaction.
Prior to founding RainMakers in 2004, Jim held various positions in the field of interest rate and equity derivatives.
Jim started his career in 1988 as a derivatives technologist, working with Sophis and SociétéGénérale CIB, developing trading and risk management models.
From 1994 to 2003, Jim held senior management positions at companies such as Opt4 Derivatives in Berkeley, California, as well as Login SA and SunGard in Paris, France. In 2003-04, Jim served as an Expert Witness for the French Department of Justice.
Jim holds an MSc in Computer Science from University of Paris VI, and an MBA from University of Chicago.



Dr. Michael J. Nowak
General Partner

Dr. Michael J. Nowak is an experienced investment banker and healthcare and high tech investor in both public and private companies. He has prior experience with healthcare and life sciences focused investment funds, family offices and boutique investment banks. He was previously a Managing Director and Head of Healthcare Investments for $B multinational hedge fund Yorkville Advisors. Before that he led investments and sat on numerous Boards of Directors while a General Partner at leading $B Euro-US fund TVM Capital. He was also a corporate venture capitalist and business development executive at Xerox PARC in Palo Alto, where he was CEO of two startups, a strategic management consultant and Vice President at McKinsey & Co., and a Program Manager at the Advanced Technology Program, National Institute of Standards and Technology, US Department of Commerce.
Mike earned an MBA from the Wharton School at the University of Pennsylvania and a PhD in Physics from the University of California, Santa Barbara. He worked as a post-doctoral scientist at Bell Labs (Bellcore), Princeton University, and at the CEA research labs in Saclay and the University of Paris VI (Jussieu) in France. He received his BA in Physics from Cornell University in Ithaca, NY, where he was a College Scholar.